Search Ontology:
ChEBI

leuprolide

Term ID
CHEBI:6427
Synonyms
  • (D-Leu(6),des-Gly-NH2(10),Pro-ethylamide(9))-gonadotropin-releasing hormone
  • 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
  • L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide
  • Leuprorelin
  • leuprorelina
  • leuproreline
  • leuprorelinum
  • pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHC2H5
  • pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt
Definition
An oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, D-leucyl, leucyl, arginyl, and N-ethylprolinamide residues joined in sequence. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant (particularly as the acetate salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty.
References
  • CAS:53714-56-0
  • DrugBank:DB00007
  • Drug_Central:1559
  • KEGG:C07612
  • KEGG:D08113
  • Patent:DE2446005
  • Patent:US4005063
  • Reaxys:741818
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
is a type of
has_role
inverse has_part
Phenotype
Phenotype resulting from leuprolide
Phenotype where environments contain leuprolide
Phenotype modified by environments containing leuprolide
Human Disease Model